Evaluating the bioequivalence and safety of liraglutide injection versus Victoza® in healthy Chinese subjects: a randomized, open, two-cycle, self-crossover phase I clinical trial

Liu, C; Xu, HR; Yuan, F; Chen, HJ; Sheng, L; Chen, WL; Xie, HS; Xu, HM; Li, XN

Li, XN (通讯作者)，Fudan Univ, Zhongshan Hosp, Dept Clin Pharmacol, Shanghai, Peoples R China.

FRONTIERS IN PHARMACOLOGY, 2023; 14 ():

Abstract

Background: Liraglutide is an acylated glucagon-like peptide-1 (GLP-1) analog, and its pharmacokinetic and pharmacodynamic properties as a GLP-1 recep......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索